Climb Bio Sees $754K in Purchases from RA Capital Funds
Overview of Climb Bio and Its Financial Highlights Climb Bio is a pioneering biotechnology company established to advance the development and commercialization of innovative gene therapies. The company is founded on the principles of harnessing cutting-edge genetic research to address unmet medical needs, particularly in rare and genetic diseases. With a mission to enhance patient … Read more